Publication | Open Access
Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma
18
Citations
31
References
2022
Year
Cancer ImmunosurveillanceDoxorubicin-induced Pd-l1 UpregulationImmunologyImmune Checkpoint InhibitorImmunosuppressive MicroenvironmentCancer TreatmentImmunotherapyMedicineRadiation OncologyTumor MicroenvironmentTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1